富祥药业：锂电池电解液添加剂VC、FEC产品价格回升，会对公司业绩产生积极影响

Core Viewpoint - The company anticipates a positive impact on its performance due to the rebound in prices of lithium battery electrolyte additives VC and FEC, and aims to leverage this market opportunity while improving overall profitability through cost enhancements in its pharmaceutical manufacturing and strategic advancements in its microbial protein business [2] Group 1: Product and Capacity - The company currently has an annual production capacity of 8,000 tons for VC products [2] - Plans are in place to increase VC production capacity to 10,000 tons per year through technological upgrades, with completion expected by the second quarter of 2026 [2] Group 2: Market Strategy - The company intends to actively seize the market opportunities presented by the rising prices of lithium battery electrolyte additives [2] - The focus will also be on improving profitability through cost reductions in the pharmaceutical manufacturing sector and advancing the microbial protein business [2]